Biotricity IncNASDAQ:BTCY
- LAST PRICE1.2200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.0100/ 7
- Ask / Lots2.0200/ 3
- Open / Previous Close0.0000 / 1.2200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BTCY |
|---|---|---|
| 09:32 ET | 194 | 1.22 |
| 09:48 ET | 1100 | 1.2 |
| 10:03 ET | 112 | 1.1842 |
| 10:30 ET | 100 | 1.2 |
| 10:32 ET | 4892 | 1.173 |
| 10:33 ET | 2103 | 1.16 |
| 10:51 ET | 101 | 1.18 |
| 10:55 ET | 220 | 1.1969 |
| 11:22 ET | 800 | 1.18 |
| 11:27 ET | 2499 | 1.18 |
| 11:33 ET | 100 | 1.2 |
| 12:25 ET | 11379 | 1.18 |
| 12:27 ET | 100 | 1.195 |
| 12:30 ET | 7800 | 1.2 |
| 12:32 ET | 747 | 1.21 |
| 12:48 ET | 100 | 1.21 |
| 01:10 ET | 4000 | 1.2 |
| 01:14 ET | 100 | 1.205 |
| 01:21 ET | 100 | 1.205 |
| 01:39 ET | 5300 | 1.205 |
| 02:04 ET | 700 | 1.205 |
| 02:38 ET | 100 | 1.2092 |
| 02:42 ET | 10330 | 1.205 |
| 02:56 ET | 100 | 1.2 |
| 03:14 ET | 191 | 1.205 |
| 03:20 ET | 1438 | 1.205 |
| 03:30 ET | 23580 | 1.215 |
| 03:32 ET | 9316 | 1.22 |
| 03:34 ET | 550 | 1.21 |
| 03:36 ET | 300 | 1.215 |
| 03:39 ET | 2449 | 1.22 |
| 03:43 ET | 300 | 1.2274 |
| 03:59 ET | 6214 | 1.22 |
Aug 5, 2022
Biotricity to Host Fiscal First Quarter 2023 Financial Results Conference Call on August 15th at 4:30 p.m. ET, from 2:30PM ET on Friday Aug 05, 2022 by Accesswire
2:30PM ET on Friday Aug 05, 2022 by Accesswire
Jul 15, 2022
--Maxim Downgrades Biotricity to Hold From Buy, from 9:52AM ET on Friday Jul 15, 2022 by MT Newswires
9:52AM ET on Friday Jul 15, 2022 by MT Newswires--Lake Street Adjusts Biotricity Price Target to $4 From $5, Maintains Buy Rating, from 9:51AM ET on Friday Jul 15, 2022 by MT Newswires
9:51AM ET on Friday Jul 15, 2022 by MT NewswiresHC Wainwright Adjusts Biotricity's Price Target to $2 from $6, Keeps Buy Rating, from 9:51AM ET on Friday Jul 15, 2022 by MT Newswires
9:51AM ET on Friday Jul 15, 2022 by MT Newswires
Jul 14, 2022
Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year, from 8:00AM ET on Thursday Jul 14, 2022 by Accesswire
8:00AM ET on Thursday Jul 14, 2022 by Accesswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biotricity Inc | 61.4M | -1.8x | --- |
Medigus Ltd | 55.7M | 2.0x | --- |
Codex DNA Inc | 65.3M | -1.5x | --- |
Milestone Scientific Inc | 76.0M | -9.9x | --- |
Precipio Inc | 36.3M | -3.1x | --- |
Pulse Biosciences Inc | 59.0M | -0.7x | --- |
Company Information
Biotricity Inc. is a medical technology company, which is focused on biometric data monitoring solutions. The Company developed its Bioflux MCT technology, comprised of a monitoring device and an ECG reporting software component. The Bioflux device is comprised of a wet electrode and worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Both the device and software are in accordance with mobile cardiac telemetry (MCT) billing code standards, compliant with arrhythmia devices and alarms, and require 510000 clearance, which has been obtained. The Bioflux device has been developed, among other things, with global system for mobile communications (GSM) mobile chip for global cellular network compatibility; touch-screen liquid crystal display (LCD) viewer; and extended battery pack for an additional approximately 48 hours of battery life.
Contact Information
- Headquarters
- 203 Redwood Parkway, Suite 600REDWOOD CITY, CA, United States 94065
- Phone
- 650-832-1626
- Fax
- ---
Executives
- Founder, Chairman, Chief Executive Officer and Executive Officer
- Waqaas Al-Siddiq
- Chief Financial Officer
- John Ayanoglou
- Director
- Patricia Kennedy
- Director
- Ronald Mcclurg
- Independent Director
- Norman Betts
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $61.4M |
|---|---|
Revenue (TTM) | $7.7M |
Shares Outstanding | 50.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.70 |
EPS | $-0.67 |
Book Value | $-0.04 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | 8.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -250.66% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
